Infusion-related reactions to infliximab (remicade®) in patients with rheumatoid arthritis:: Relationship to dose, anti-histamine pre-treatment and infusion number

被引：0
|
作者：
Wasserman, MJ [1 ]
Weber, DA [1 ]
Guthrie, JA [1 ]
Mitroi, E [1 ]
Bykerk, V [1 ]
Lee, P [1 ]
Keystone, EC [1 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Ctr Adv Therapeut, Toronto, ON M5G 1X5, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2003年 / 30卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1888 / 1888
页数：1
相关论文
共 50 条
  • [31] Patients with infusion-related reactions on fixed-dose rituximab treatment have higher body surface area than those without infusion-related reactions in adults with frequently relapsing minimal change nephrotic syndrome: a retrospective study
    Hironobu Nishiura
    Masaya Takahashi
    Katsuhito Mori
    Takashi Sugimoto
    Masanori Emoto
    Yasutaka Nakamura
    Journal of Pharmaceutical Health Care and Sciences, 10
  • [32] Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis
    Okuyama, Ayumi
    Nagasawa, Hayato
    Suzuki, Katsuya
    Kameda, Hideto
    Kondo, Harumi
    Amano, Kouichi
    Takeuchi, Tsutomu
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (02) : 299 - 304
  • [33] Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis
    Conti, Fabrizio
    Ceccarelli, Fulvia
    Perricone, Carlo
    Alessandri, Cristiano
    Conti, Virginia
    Massaro, Laura
    Truglia, Simona
    Spinelli, Francesca R.
    Spadaro, Antonio
    Valesini, Guido
    RHEUMATOLOGY, 2011, 50 (06) : 1148 - 1152
  • [34] Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
    Ellis, Lorie A.
    Malangone-Monaco, Elisabetta
    Varker, Helen
    Stetsovsky, Diana
    Kubacki, Maureen
    DeHoratius, Raphael J.
    Kafka, Shelly
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 99 - 109
  • [35] DOSES AND INFUSION INTERVALS FOR INFLIXIMAB IN ANTI-TNF NAIVE AND ANTI-TNF EXPERIENCED MANAGED CARE PATIENTS WITH RHEUMATOID ARTHRITIS
    Carter, C.
    Tang, B.
    Changolkar, A.
    McKenzie, R. S.
    Piech, C. T.
    VALUE IN HEALTH, 2010, 13 (03) : A135 - A135
  • [36] Frequent infusion reactions associated with infliximab treatment in patients with polyarthritis related to systemic lupus erythematosus.
    Katz, RS
    Holt-Daly, N
    MacDonald, PA
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S379 - S379
  • [37] Infusion-related reactions with vedolizumab treatment in patients with UC or CD during the GEMINI 1 and GEMINI 2 clinical trials
    Sands, B. E.
    Cohen, R.
    Isaacs, K.
    Fedorak, R. N.
    Abhyankar, B.
    Sankoh, S.
    Smyth, M.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S392 - S393
  • [38] Infusion-Related Reactions With Vedolizumab Treatment in Patients With UC or CD During the GEMINI 1 and GEMINI 2 Clinical Trials
    Sands, Bruce E.
    Cohen, Russell D.
    Isaacs, Kim L.
    Fedorak, Richard N.
    Abhyankar, Brihad
    Sankoh, Serap
    Smyth, Michael D.
    GASTROENTEROLOGY, 2015, 148 (04) : S232 - S233
  • [39] Evaluating the relationship between infusion-related reactions and anti-drug antibody status: Results from 111 patients with Fabry disease treated with pegunigalsidase alfa
    Hopkina, Robert J.
    Hughesb, Derralynn
    Bernatc, John A.
    Linhartd, Ales
    Longoe, Nicola
    Tondelf, Camilla
    Vujkovacg, Bojan
    Pisanih, Antonio
    Knolli, Jasmine
    Koulinskaj, Irene
    Piottij, Giovanni
    Chertkoffk, Raul
    Alonk, Sari
    Sakovl, Anat
    Wallacem, Eric L.
    MOLECULAR GENETICS AND METABOLISM, 2025, 144 (02)
  • [40] Responsiveness to anti-tumour necrosis factor α therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients
    Kraan, T. C. van der Pouw
    Wijbrandts, C. A.
    van Baarsen, L. G.
    Rustenburg, F.
    Baggen, J. M.
    Verweij, C. L.
    Tak, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (04) : 563 - 566
12345